Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Received Approval to Be Entered Into the Australian Register of Therapeutic Goods (ARTG) for use against COVID-19 May 28, 2020
Sonoma Pharmaceuticals Announces Expanded Distribution Agreement with Brill International S.L. for Europe and approval of new CE Marking for Microdacyn60® Eye Care May 26, 2020
Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group Feb 27, 2020
Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division Jan 23, 2020
Sonoma Pharmaceuticals Announces Closing of $1.6 Million Public Offering of Common Stock Nov 29, 2019
Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common Stock Nov 26, 2019
